S 4338 · 117th Congress
Increasing Transparency in Generic Drug Applications Act
This bill requires the FDA to be more open about what happens when companies apply to sell generic versions of brand-name drugs. Right now, when a pharmaceutical company submits an application to make a generic drug, much of that information stays confidential. This bill would require the FDA to publicly disclose de…
- Sponsor
- Hassan, Margaret Wood (D-NH)
- Introduced
- 2022-05-26
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Digging through Congress... 🔍